Navigation

ExploreAnalysisInvestor RelationsAI AssistantCompareScreener
LoginSign Up FreeSign Up

© 2026 MarketCI. All rights reserved.

HelpPricingPrivacyTerms
PR

PRGO

Market Closed

Perrigo Company plc

NYSEHealthcareDrug Manufacturers - Specialty & Generic
IE
8.10K employees
CEO: Albert A. Manzone
Founded: 1991
$16.62
+$0.00(+NaN%)
Market Cap
2.31B
Beta
0.54
52W Range
N/A
Dividend Yield
6.98%
OverviewForecastsFundamentalMarket SentimentValuationOwnership
OverviewForecastsFundamentalMarket SentimentValuationOwnership
Comprehensive Valuation
In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Perrigo’s current price of $16.63 is substantially below the high-confidence fair value estimate of $47.75, indicating significant upside potential with low downside risk (3.7%). Despite weak profitability and efficiency scores, strong liquidity and growth metrics and wide Monte Carlo scenario outcomes reflect high valuation uncertainty and volatility. The valuation blend leans heavily on DCF and analyst targets, supporting an undervalued status amid financial health concerns.
Enhanced Football Field Analysis
Loading comprehensive valuation data...

Fetching multi-methodology valuation ranges...

Explore PRGO

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

PRGO in the Healthcare

Mid Cap
Healthcare

Browse sector stocks →

Drug Manufacturers - Specialty & Generic

Browse industry stocks →